Showing results (771-780 of 1,494) with videos related to

Sort By:
Pageof 150
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 5, 2026
Accuracy, Usefulness, and Impact Variability of ChatGPT-4 for COPD Medication Management: A Modified Delphi StudyPaul M Boylan, Devin L Lavender, Rebecca H Stone, et al.
Journal of Strength and Conditioning Research|October 12, 2020
Utility of a Shortened Isometric Midthigh Pull Protocol for Assessing Rapid Force Production in AthletesDylan G Suarez, Kevin M Carroll, Jake A Slaton, et al.
Public Health|October 5, 2023
Enhanced EPIRISK tool for rapid epidemic risk analysisX Chen, M P Kunasekaran, D Hutchinson, et al.
International Journal of Sport Nutrition|June 1, 1992
Efficacy of chromium supplementation in athletes: emphasis on anabolismR G Lefavi, R A Anderson, R E Keith, et al.
The Annals of Thoracic Surgery|November 5, 2013
Stingray barb injury: a cause of late coronary occlusion and stent failureCraig R Saunders, Enrique Saro, Parag Patel, et al.
Clinical Pharmacology and Therapeutics|April 1, 1977
Leucovorin in combination chemotherapy of breast cancerM P Corder, R F Sheets, W H Stone, et al.
Proceedings of the Institution of Mechanical Engineers. Part H, Journal of Engineering in Medicine|December 8, 2000
Influence of gelatin and bovine serum lubricants on ultra-high molecular weight polyethylene wear debris generated in in vitro simulationsJ Bell, A A Besong, J L Tipper, et al.
Acta Crystallographica. Section E, Crystallographic Communications|May 8, 2023
Formation of Ba3Nb0.75Mn2.25O9-6H during thermo-chemical reduction of Ba4NbMn3O12-12RNicholas A Strange, Robert T Bell, James Eujin Park, et al.
Developmental and Comparative Immunology|January 1, 1991
Cellular immune response of a marsupial, Monodelphis domesticaA J Infante, N K Samples, D A Croix, et al.
Annals of Internal Medicine|October 1, 1996
Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study GroupR C Pasternak, L E Brown, P H Stone, et al.
Pageof 150